Suqian Aier ophthalmic hospital: at present, the information transmitted online has been rectified in 2019, and the illegal employees have been seriously dealt with
Financial Associated Press, Jan. 9 (Xinhua) -- Suqian Aier ophthalmic hospital said that it attached great importance to the recent online information related to the non-standard business behavior of our hospital. After preliminary verification, it is hereby declared as follows: according to the current online information, our hospital has carried out rectification according to the relevant requirements of the board of directors in 2019, seriously dealt with the illegal employees and replaced the management team. The current leadership took this as a lesson to further strengthen hospital management and adhere to standardized operation. At the same time, strengthen the daily education of employees and improve the service level. Strive to win patient satisfaction and social recognition with advanced technology and excellent service.
This text is a result of machine translation.
Related companies：
Briefing Apr 27, 2022 05:16 PM
Beautiful Ecology: the net profit in the first quarter increased by 24.92% to 1.9755 million yuan
Briefing Apr 25, 2022 06:25 PM
· Healthcare
Yingkang life: it is expected to lose 300 million yuan to 370 million yuan in 2021
In-depth
Healthcare
IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives
In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow
May 09, 2024 12:18 PM
Digital Zhengtong: new orders signed in the first two months increased by more than 60% year-on-year
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 18, 2022 06:30 PM
Healthcare
Sino Biopharm and Boehringer Ingelheim Sign Option and License Deal for Six Cancer Programs
Sino Biopharmaceutical（中国生物制药）and Boehringer Ingelheim（勃林格殷格翰）announced an option and license agreement on November 4 covering six preclinical cancer programs. Sino Biopharm will receive USD 358 million in upfront and near-term payments and may receive up to USD 7 billion in additional option, development, regulatory and commercial milestone payments.
Nov 05, 2026 11:22 AM
Briefing Oct 29, 2021 11:38 AM
Financial Associated Press, October 29 - a carbon monoxide poisoning accident occurred in an ironmaking plant in Xingtai, Hebei Province. Three people died after ineffective rescue.
Briefing Oct 19, 2021 06:23 PM
Aier ophthalmology: acquisition of partial equity of Anshan Aier, Cangzhou Aier, Fuyang Aier, Langfang Aier and Qinhuangdao Aier
Briefing Sep 03, 2021 06:03 PM
· Healthcare
Suzhou gutechnetium: the controlling shareholder completed the reduction of 3% shares
Briefing Aug 26, 2021 06:37 PM
· Healthcare
Aier ophthalmology: the net profit in the first half of the year was 1.116 billion yuan, a year-on-year increase of 65.03%
See more
Read next
Insight
In-depth
Mobility · Analysis
Global Expansion Fuels BYD's Profit Recovery Above RMB 10 Billion
Updated 3 hours ago
Insight
In-depth
Disruptive Competitiveness: The Missing Piece in the Sovereignty Puzzle
Updated 8 hours ago
Insight
In-depth
AI · Analysis
Revenue Up 283%, Over 60% From Overseas: MiniMax's Global Expansion
Nov 05, 2026 08:41 PM
Insight
In-depth
Mobility · Analysis
How BYD Is Turning China's EV Advantages into Global Growth
Nov 05, 2026 08:35 PM